Ledger.Open graph →
SEC Form D · filed January 31, 2017

Focal Point Pharmaceuticals, Inc

Offering
$80K
Sold
$80K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MEMPHIS, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Gary Prosterman · Memphis, TNExec · DirectorRaymond Hage · Memphis, TNExec · DirectorScott Langille · Burlington, Ontario, CanadaExec · DirectorRaymond Stone · Burlington, Ontario, CanadaExec · DirectorGavin J. Saitowitz · New York, NYExec · DirectorCisco J. Del Valle · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗